Indaptus Therapeutics Inc (INDP)
2.25
-0.07
(-3.02%)
USD |
NASDAQ |
Jun 21, 16:00
2.30
+0.05
(+2.22%)
Pre-Market: 09:13
Indaptus Therapeutics Total Assets (Quarterly): 10.95M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 10.95M |
| December 31, 2023 | 14.92M |
| September 30, 2023 | 17.79M |
| June 30, 2023 | 20.84M |
| March 31, 2023 | 23.14M |
| December 31, 2022 | 28.06M |
| September 30, 2022 | 30.45M |
| Date | Value |
|---|---|
| June 30, 2022 | 34.06M |
| March 31, 2022 | 37.09M |
| December 31, 2021 | 40.58M |
| September 30, 2021 | 43.86M |
| June 30, 2021 | 20.09M |
| December 31, 2020 | 1.778M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
1.778M
Minimum
Dec 2020
43.86M
Maximum
Sep 2021
24.89M
Average
23.14M
Median
Mar 2023
Total Assets (Quarterly) Benchmarks
| Oragenics Inc | 3.534M |
| Rezolute Inc | 87.74M |
| GT Biopharma Inc | 9.912M |
| IGM Biosciences Inc | 376.13M |
| 180 Life Sciences Corp | 3.442M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.588M |
| Shareholders Equity (Quarterly) | 9.361M |